Healthcare
Paramount Bed Holdings Co., Ltd.(PBHDF)
Live Price
Offline$19.74
+0.00% today
Window Change
+0.00%
Window
Jun 23, 2025 โ Mar 27, 2026
- Market Cap
- $1.15B
- Revenue Growth
- +2.4%
- EPS Growth
- -12.8%
- Dividend Yield
- 3.2%
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 167 bars ยท Jun 23, 2025 โ Mar 27, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Paramount Bed Holdings Co., Ltd. (PBHDF) is a Healthcare stock with a market cap of $1.15B and listed on OTC. The stock last traded around $19.74 and up 0.0% across the available one-year price window (Jun 23, 2025 โ Mar 27, 2026). Baseline metrics include revenue growth of +2.4%, EPS growth of -12.8%, a dividend yield of 3.2%. What stands out right now is revenue +2.4%, EPS -12.8%, free cash flow +82.2% with operating margin 10.8% and ROIC 5.1%. The dividend matters to the case here, with a current yield around 3.2%. Valuation is more restrained than many high-expectation growth names at P/E 21.5 and price/sales 1.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PBHDF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+2.4% vs +7.6% peer median
Operating Margin
Below sector median
+10.8% vs +19.4% peer median
P/E
Below sector median
21.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 20, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +2.4% and EPS is at -12.8%, with operating margin around 10.8%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 3.2%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -33.3% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 27, 2026 | โ | +0.0% | -100.0% | โ |
2025 Oct 28, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 Jul 28, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PBHDF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PBHDF Max Drawdown
-100.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PBHDF and SPY.
Company Overview
Paramount Bed Holdings Co., Ltd.
Other OTC
Paramount Bed Holdings Co., Ltd. manufactures and sells hospital and nursing care beds worldwide. The company offers mattresses and equipment for medical treatment and nursing care environments; and home care products. It also engages in the inspection and maintenance of Paramount bed products; and leasing and wholesale of welfare care products. The company was founded in 1947 and is headquartered in Tokyo, Japan.
- Leadership
- Tomohiko Kimura
- IPO Date
- Jan 26, 2017
- Employees
- 3.9k
- Street Address
- 2-14-5 Higashisuna
- Mailing
- Tokyo, 136-8671
- Region
- Tokyo, JP
- Reporting Currency
- USD
- Investor Line
- 81 3 3648 1100
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 21.5
- EV/EBITDA
- 7.4
- Price/Sales
- 1.8
- Price/Book
- 1.4
Growth
- Revenue
- +2.4%
- EPS
- -12.8%
- Free Cash Flow
- +82.2%
Profitability
- Gross Margin
- 48.9%
- Operating Margin
- 10.8%
- Net Margin
- 8.6%
- ROE
- 6.7%
- ROIC
- 5.1%
Balance Sheet
- Debt/Equity
- 0.05
- Current Ratio
- 3.85
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.